Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2109863517;63518;63519 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
N2AB1945758594;58595;58596 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
N2A1853055813;55814;55815 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
N2B1203336322;36323;36324 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
Novex-11215836697;36698;36699 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
Novex-21222536898;36899;36900 chr2:178588115;178588114;178588113chr2:179452842;179452841;179452840
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-41
  • Domain position: 35
  • Structural Position: 37
  • Q(SASA): 0.0742
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/R None None 0.999 N 0.865 0.387 0.577962725263 gnomAD-4.0.0 1.59318E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86159E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.647 likely_pathogenic 0.6761 pathogenic -0.725 Destabilizing 0.996 D 0.63 neutral N 0.471384195 None None N
G/C 0.8663 likely_pathogenic 0.8769 pathogenic -0.861 Destabilizing 0.844 D 0.782 deleterious None None None None N
G/D 0.9794 likely_pathogenic 0.98 pathogenic -1.638 Destabilizing 0.998 D 0.773 deleterious None None None None N
G/E 0.9836 likely_pathogenic 0.9858 pathogenic -1.58 Destabilizing 0.999 D 0.835 deleterious N 0.46996539 None None N
G/F 0.991 likely_pathogenic 0.9922 pathogenic -0.747 Destabilizing 1.0 D 0.872 deleterious None None None None N
G/H 0.9857 likely_pathogenic 0.9865 pathogenic -1.514 Destabilizing 1.0 D 0.862 deleterious None None None None N
G/I 0.9899 likely_pathogenic 0.99 pathogenic -0.032 Destabilizing 1.0 D 0.867 deleterious None None None None N
G/K 0.9934 likely_pathogenic 0.9938 pathogenic -1.195 Destabilizing 0.999 D 0.836 deleterious None None None None N
G/L 0.9875 likely_pathogenic 0.9889 pathogenic -0.032 Destabilizing 0.999 D 0.835 deleterious None None None None N
G/M 0.9916 likely_pathogenic 0.9931 pathogenic -0.156 Destabilizing 1.0 D 0.866 deleterious None None None None N
G/N 0.9698 likely_pathogenic 0.9718 pathogenic -1.134 Destabilizing 0.91 D 0.446 neutral None None None None N
G/P 0.9996 likely_pathogenic 0.9995 pathogenic -0.222 Destabilizing 1.0 D 0.868 deleterious None None None None N
G/Q 0.9772 likely_pathogenic 0.9792 pathogenic -1.158 Destabilizing 1.0 D 0.876 deleterious None None None None N
G/R 0.9717 likely_pathogenic 0.9735 pathogenic -1.057 Destabilizing 0.999 D 0.865 deleterious N 0.477220318 None None N
G/S 0.5231 ambiguous 0.5533 ambiguous -1.422 Destabilizing 0.997 D 0.657 neutral None None None None N
G/T 0.9273 likely_pathogenic 0.9287 pathogenic -1.282 Destabilizing 0.999 D 0.822 deleterious None None None None N
G/V 0.9791 likely_pathogenic 0.9797 pathogenic -0.222 Destabilizing 0.999 D 0.837 deleterious N 0.510012241 None None N
G/W 0.9815 likely_pathogenic 0.9816 pathogenic -1.346 Destabilizing 1.0 D 0.84 deleterious None None None None N
G/Y 0.9835 likely_pathogenic 0.983 pathogenic -0.827 Destabilizing 1.0 D 0.871 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.